Paul Hoskins

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

Medicine, Oncology, Pharmacology +15

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai et al. · Blood · 2006 · 1.5K citations

Medicine, Hematology, Oncology +5

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

Randy D. Gascoyne, Sheryle A. Adomat, Stanisław Krajewski et al. · Blood · 1997 · 499 citations · Full text

Medicine, Oncology, Pathology +13

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Abdulwahab J. Al-Tourah, Karamjit Gill, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2008 · 373 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Amit M. Oza, Laurie Elit, Ming‐Sound Tsao et al. · Journal of Clinical Oncology · 2011 · 338 citations · Full text

Medicine, Oncology, Pharmacology +15